EdgarLookup

CITIUS ONCOLOGY, INC.

CTOR NASDAQ CIK: 0001851484 Pharmaceutical Preparations Inc. in DE
View on SEC.gov →
Overview All Filings Annual Quarterly Insiders

Recent Filings

All 233 filings →
Form Description Date
8-K CURRENT REPORT Mar 10, 2026
8-K CURRENT REPORT Mar 4, 2026
EFFECT — Mar 2, 2026
POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 Feb 20, 2026
SCHEDULE 13G/A — Feb 17, 2026
8-K CURRENT REPORT Feb 13, 2026
10-Q QUARTERLY REPORT Feb 13, 2026
DEF 14C DEFINITIVE INFORMATION STATEMENT Jan 29, 2026
PRE 14C PRELIMINARY INFORMATION STATEMENT Jan 20, 2026
EFFECT — Jan 12, 2026

Insider Transactions

View all →
Insider Title Type Shares Owns After Date
Webb Carol — Award / Grant 300,000 300,000 Sep 19, 2025
Czuczman Myron Chief Medical Officer Award / Grant 825,000 825,000 Sep 19, 2025
HOLUBIAK MYRON Z Secretary Award / Grant 850,000 850,000 Sep 19, 2025
Mazur Leonard L Chief Executive Officer Award / Grant 1,700,000 1,700,000 Sep 19, 2025
Bartushak Jaime Chief Financial Officer Award / Grant 825,000 825,000 Sep 19, 2025
Smith Robert Joseph — Award / Grant 300,000 300,000 Sep 19, 2025
Mayersohn Joel David — Award / Grant 300,000 321,228 Sep 19, 2025
MCGRATH DENNIS M — Award / Grant 300,000 300,000 Sep 19, 2025
Dutia Suren G — Award / Grant 300,000 300,000 Sep 19, 2025
Holuka Eugene Myron — Award / Grant 300,000 300,000 Sep 19, 2025